Showing results (101-110 of 154) with videos related to
Sort By:
Pageof 16
The Medical Journal of Australia|April 20, 2000
Getting new evidence into medicineG L Rubin, M S Frommer, N C Vincent, et al.Clinical and Experimental Pharmacology & Physiology|June 1, 1993
Monoclonal antibodies to arginine vasopressin receptor bind to liver, kidney and pituitary membranesD Trinder, V Mooser, P A Phillips, et al.Clinical and Experimental Pharmacology & Physiology|April 1, 1992
Isolation and characterization of the rat liver AVP receptor using [125I][d(CH2)5'sarcosine7]AVPD Trinder, J M Kelly, R Fernley, et al.Clinical Science (London, England : 1979)|June 1, 1985
Angiotensin II-induced thirst and vasopressin release in manP A Phillips, B J Rolls, J G Ledingham, et al.Clinical and Experimental Pharmacology & Physiology|May 1, 1993
Effects of an orally active vasopressin V1 receptor antagonistL M Burrell, P A Phillips, J Stephenson, et al.Clinical and Experimental Pharmacology & Physiology|January 1, 1994
Effects of anti-emetics on water excretion in humansP A Phillips, L M Burrell, J Risvanis, et al.Endocrinology|March 1, 1990
Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligandsP A Phillips, J M Abrahams, J M Kelly, et al.The Journal of Endocrinology|August 1, 1993
Characterization of a novel non-peptide vasopressin V1 receptor antagonist (OPC-21268) in the ratL M Burrell, P A Phillips, J Stephenson, et al.The American Journal of Medicine|December 26, 1989
Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonistsC I Johnston, P G Hodsman, M Kohzuki, et al.Journal of Travel Medicine|October 17, 1998
Safety of mefloquine and other antimalarial agents in the first trimester of pregnancyP A Phillips-Howard, R Steffen, L Kerr, et al.Pageof 16